Cargando…
Investigating the impact of prior COVID‐19 on IgG antibody and interferon γ responses after BBIBP‐CorV vaccination in a disease endemic population: A prospective observational study
BACKGROUND AND AIMS: COVID‐19 vaccinations have reduced morbidity and mortality from the disease. Antibodies against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) have been associated with immune protection. Seroprevalence studies revealed high immunoglobulin G (IgG) antibody levels t...
Autores principales: | Hasan, Zahra, Masood, Kiran Iqbal, Qaiser, Shama, Khan, Erum, Hussain, Areeba, Ghous, Zara, Khan, Unab, Yameen, Maliha, Hassan, Imran, Nasir, Muhammad Imran, Qazi, Muhammad Farrukh, Memon, Haris Ali, Ali, Shiza, Baloch, Sadaf, Bhutta, Zulfiqar A., Veldhoen, Marc, Pedro Simas, J., Mahmood, Syed Faisal, Ghias, Kulsoom, Hussain, Rabia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486204/ https://www.ncbi.nlm.nih.gov/pubmed/37692793 http://dx.doi.org/10.1002/hsr2.1521 |
Ejemplares similares
-
BBIBP-CorV: Hepatitis: case report
Publicado: (2022) -
IgG antibodies to SARS-CoV-2 in asymptomatic blood donors at two time points in Karachi
por: Hasan, Muhammad, et al.
Publicado: (2022) -
BBIBP-CorV: Anterior uveitis: case report
Publicado: (2022) -
Humoral and T cell responses to SARS-CoV-2 reveal insights into immunity during the early pandemic period in Pakistan
por: Masood, Kiran Iqbal, et al.
Publicado: (2023) -
Persistence of immune responses to the Sinopharm/BBIBP‐CorV vaccine
por: Jeewandara, Chandima, et al.
Publicado: (2022)